TR200001040T2 - Kaşıntıyı önleme etkisi için bileşiklerin yeni bir kullanımı - Google Patents

Kaşıntıyı önleme etkisi için bileşiklerin yeni bir kullanımı

Info

Publication number
TR200001040T2
TR200001040T2 TR2000/01040T TR200001040T TR200001040T2 TR 200001040 T2 TR200001040 T2 TR 200001040T2 TR 2000/01040 T TR2000/01040 T TR 2000/01040T TR 200001040 T TR200001040 T TR 200001040T TR 200001040 T2 TR200001040 T2 TR 200001040T2
Authority
TR
Turkey
Prior art keywords
compounds
new use
itch effect
itch
effect
Prior art date
Application number
TR2000/01040T
Other languages
English (en)
Inventor
E. Griswold Don
Benjamin Christensen Siegfried Iv
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of TR200001040T2 publication Critical patent/TR200001040T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Kasinti olusturan hastaliklarin veya rahatsizliklarin önleme veya tedavisinde kullanilan 8-baska maddelerle degistirilmis iksantinlerin türevleri
TR2000/01040T 1997-10-17 1998-10-16 Kaşıntıyı önleme etkisi için bileşiklerin yeni bir kullanımı TR200001040T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6374697P 1997-10-17 1997-10-17

Publications (1)

Publication Number Publication Date
TR200001040T2 true TR200001040T2 (tr) 2001-01-22

Family

ID=22051225

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/01040T TR200001040T2 (tr) 1997-10-17 1998-10-16 Kaşıntıyı önleme etkisi için bileşiklerin yeni bir kullanımı

Country Status (18)

Country Link
EP (1) EP1030666A4 (tr)
JP (1) JP2001520196A (tr)
KR (1) KR20010031149A (tr)
CN (1) CN1306426A (tr)
AR (1) AR015966A1 (tr)
AU (1) AU740875B2 (tr)
BR (1) BR9814080A (tr)
CA (1) CA2306985A1 (tr)
CO (1) CO4810374A1 (tr)
CZ (1) CZ20001376A3 (tr)
HU (1) HUP0003792A3 (tr)
IL (1) IL135581A0 (tr)
NO (1) NO20001847L (tr)
NZ (1) NZ503551A (tr)
PL (1) PL341062A1 (tr)
TR (1) TR200001040T2 (tr)
WO (1) WO1999020280A1 (tr)
ZA (1) ZA989450B (tr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2248231T3 (es) 2001-01-31 2006-03-16 Pfizer Products Inc. Derivados de eteres utiles como inhibidores de las isozimas pde4.
US7250518B2 (en) 2001-01-31 2007-07-31 Pfizer Inc. Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
CN1489588A (zh) 2001-01-31 2004-04-14 �Ʒ� 用作pde4同功酶抑制剂的噻唑基,噁唑基,吡咯基,和咪唑基羧酸酰胺衍生物
EE200300360A (et) 2001-01-31 2003-12-15 Pfizer Products Inc. PDE4 isosüümide inhibiitoritena kasutatavad nikotiinamiidi biarüülderivaadid
US20030175314A1 (en) * 2001-11-19 2003-09-18 Didriksen Erik Johannes Pharmaceutical composition for dermal application
US20060258703A1 (en) * 2003-07-17 2006-11-16 Ono Pharmaceutical Co., Ltd. Remedy for pruritus comprising piperidine derivative as the active ingredient
WO2005053672A1 (ja) * 2003-12-04 2005-06-16 Santen Pharmaceutical Co., Ltd. シロミラストまたはその塩を有効成分とする掻痒治療剤
JP2005187458A (ja) * 2003-12-04 2005-07-14 Santen Pharmaceut Co Ltd シロミラストまたはその塩を有効成分とする掻痒治療剤
PL1781657T3 (pl) 2004-02-14 2013-08-30 Glaxosmithkline Ip Dev Ltd Leki o aktywności wobec receptora HM74A
JP2008137892A (ja) * 2005-03-04 2008-06-19 Eisai Co Ltd 止痒剤
ES2401128T3 (es) 2005-08-10 2013-04-17 Glaxosmithkline Llc Derivados de xantina como agonistas selectivos de HM74A
TWI404709B (zh) * 2006-02-21 2013-08-11 Eisai R&D Man Co Ltd 4- (3-benzamidophenyl) -6,7-dimethoxy-2-methylamine quinazoline derivatives
AU2007218725B2 (en) * 2006-02-21 2011-12-01 Eisai R & D Management Co., Ltd. 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2- methylaminoquinazoline derivative
US8530654B2 (en) 2007-02-16 2013-09-10 Eisai R&D Management Co., Ltd. Crystals, amorphous substances or salts of methyl N-[3-(6,7-dimethoxy-2-methylaminoquinazolin-4-yl) phenyl] terephthalamic acid
CA2696793A1 (en) 2007-08-17 2009-02-26 Eisai R&D Management Co., Ltd. Novel preparation for external use
AU2008290000B2 (en) 2007-08-17 2012-05-10 Eisai R & D Management Co., Ltd. Method for producing quinazoline derivative
ES2659458T3 (es) * 2011-06-28 2018-03-15 Mitsubishi Tanabe Pharma Corporation Compuestos de naftaleno para tratar el prurito
EP3251675B1 (en) 2015-01-30 2021-04-21 Shanton Pharma Pte. Ltd. Prevention or treatment of uric acid or gout disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2148170T3 (es) * 1990-12-21 2000-10-16 Beecham Group Plc Derivados de xantina.
SI0889886T1 (en) * 1996-03-26 2003-02-28 Altana Pharma Ag Novel phenanthridines substituted in the 6 position
ES2187775T3 (es) * 1996-05-15 2003-06-16 Altana Pharma Ag Imidazopiridinas.
SI0968211T1 (en) * 1997-03-07 2004-02-29 Altana Pharma Ag Tetrazole derivatives
SK122199A3 (en) * 1997-03-18 2000-12-11 Basf Ag Methods and compositions for modulating responsiveness to corticosteroids
ES2193539T3 (es) * 1997-06-03 2003-11-01 Altana Pharma Ag Benzonaftiridinas.

Also Published As

Publication number Publication date
HUP0003792A2 (hu) 2001-10-28
CN1306426A (zh) 2001-08-01
EP1030666A1 (en) 2000-08-30
NO20001847D0 (no) 2000-04-10
CO4810374A1 (es) 1999-06-30
CA2306985A1 (en) 1999-04-29
ZA989450B (en) 1999-04-19
EP1030666A4 (en) 2002-10-16
JP2001520196A (ja) 2001-10-30
IL135581A0 (en) 2001-05-20
WO1999020280A1 (en) 1999-04-29
KR20010031149A (ko) 2001-04-16
BR9814080A (pt) 2000-09-26
AU1093899A (en) 1999-05-10
CZ20001376A3 (cs) 2002-06-12
HUP0003792A3 (en) 2001-12-28
AU740875B2 (en) 2001-11-15
NZ503551A (en) 2002-05-31
AR015966A1 (es) 2001-05-30
NO20001847L (no) 2000-04-10
PL341062A1 (en) 2001-03-26

Similar Documents

Publication Publication Date Title
TR200001040T2 (tr) Kaşıntıyı önleme etkisi için bileşiklerin yeni bir kullanımı
TR200103233T2 (tr) Antikolinerjik etkili bileşik ve ß-mimetikler bazında yeni ilaç bileşimleri.
SV1995000007A (es) Derivados del acido micofenolico 5-substituidos.
ES2060310T3 (es) Utilizacion de la n-miristoil-(s)-fenilalanina para la obtencion de medicamentos destinados al tratamiento de enfermedades que hacen intervenir la miristoilacion.
EA200300628A1 (ru) Соединения, специфические к аденозиновому a, aи aрецептору, и их применение
PT797439E (pt) Utilizacao de pramipexote como agente neuroprotector
CY1105144T1 (el) Χρηση μιας ουσιας που συνδεεται στον πepιφepειακο υποδοχεα των βενζοδιαζεπινων στη θepαπεια του δepματικου στρες
TR199800815A2 (tr) Sülfonilaminokarbonasitler.
TR200101722T2 (tr) Serivastatin ve fibratların birleşimi.
ATE231872T1 (de) Thiazolopyrimidinderivate
ES2192839T3 (es) Timosina beta 4 oxidada.
PL323490A1 (en) Tetralinic compounds exibiting acitity against multgiple-drug refractoriness
IT1285770B1 (it) Composti corticoidei
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
ES2167401T3 (es) Uso de ascorbil-gamma-linolenato o un ascorbil-dihomo-gamma-linolenato para el tratamiento de asma, cancer, enfermedades cardiovasculares y anti-inflamatorias.
TR199900505T2 (tr)
IL115589A0 (en) Use of cck-b antagonists in pharmaceutical compositions
TR199802351T2 (tr) Topikal kullanim için bir veya birden fazla lokal anestezik ve anti-vajinit maddeler ihtiva eden anti-vajinit bilesimi.
MD1716C2 (ro) Utilizare a melatoninei pentru tratamentul pacienţilor dependenţi de benzodiazepine
NO20005548D0 (no) Mykobakterieinhibitorer
BR0313230A (pt) Uso de carboxamidas para o tratamento de tinido
TR199801798T2 (tr) Otizm tedavisi.
ES2150418T3 (es) Composiciones farmaceuticas que comprenden calcitonina.
ES2173180T3 (es) Derivados del mercaptoacetilamida hipocolesterolemicos, antiateroescleroticos e hipotrigliceridemicos.
ATE207357T1 (de) Verwendung von cotinin zur linderung des tabakentzugssyndrom